- CRYSTALLINE FORMS FENOLDOPAM MESYLATE
-
The invention provides new crystalline forms of fenoldopam mesylate, i.e. fenoldopam mesylate Type I, fenoldopam mesylate Type III, fenoldopam mesylate Type V, and fenoldopam mesylate Type VI, methods of preparing the crystalline forms, and pharmaceutical compositions comprising the fenoldopam mesylate crystalline forms of the invention.
- -
-
Page/Page column 18-19
(2010/11/26)
-
- Process for the preparation of Fenoldopam Mesylate
-
Methods and intermediates for the preparation of Fenoldopam mesylate and intermediates thereof are provided.
- -
-
Page/Page column 7-8
(2008/06/13)
-
- Solid oral preparation containing a pyrrolidine derivative with a catechol group
-
An oral solid preparation comprising an organic acid or its salt and a catechol compound. The catechol compound is, for example, a pyrrolidine derivative having a catechol group of the following general formula (I). It exhibits an improved absorbability in vivo. STR1
- -
-
-